"Medisch Centrum Anima heeft zich gespecialiseerd in niet-invasieve hersenstimulatie (tDCS)."

During the past decade, Anima conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anima" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials sponsored, "Janssen-Cilag International NV" with 1 trials sponsored and "Janssen-Cilag Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anima" #1 collaborator was "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator and "International Vaccine Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Anima" are "Depressive Disorder, Major" (5 trials), "Anhedonia" (1 trials), "COVID-19" (1 trials), "COVID-19 Prevention" (1 trials) and "Extraintestinal Pathogenic Escherichia Coli Prevention" (1 trials). Many other conditions were trialed in "Anima" in a lesser frequency.

Most popular intervention types in "Anima" are "Drug" (6 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ad26.COV2.S" (2 trials), "Aticaprant" (2 trials), "SSRI/SNRI" (2 trials) and "Ad26.RSV.preF-based Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anima" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Anima". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Anima, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Anima, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".